A Trademark

Trademark Overview

On Wednesday, April 19, 2017, a trademark application was filed for A with the United States Patent and Trademark Office. The USPTO has given the A trademark a serial number of 87416898. The federal status of this trademark filing is REGISTERED as of Tuesday, April 12, 2022. This trademark is owned by Adare Pharmaceuticals, Inc.. The A trademark is filed in the Treatment & Processing of Materials Services and Computer & Software Services & Scientific Services categories with the following description:

Manufacturing of oral drug delivery formulations, to the specifications of others, used as facilitating agents for pharmaceutical tablets and capsules, vitamins, food supplements, and animal veterinary tablets and capsules

Design and development of pharmaceutical formulations; Research and development of oral drug delivery formulation used as facilitating agents for pharmaceutical tablets and capsules, vitamins, food supplements, and animal veterinary tablets and capsules; Development of pharmaceutical preparations in liquid time release form
a

General Information

Serial Number87416898
Word MarkA
Filing DateWednesday, April 19, 2017
Status700 - REGISTERED
Status DateTuesday, April 12, 2022
Registration Number6701677
Registration DateTuesday, April 12, 2022
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, March 6, 2018

Trademark Statements

Goods and ServicesManufacturing of oral drug delivery formulations, to the specifications of others, used as facilitating agents for pharmaceutical tablets and capsules, vitamins, food supplements, and animal veterinary tablets and capsules
Description of MarkThe mark consists of a capital letter "A" dissected in the middle by a circle located above the bottom half of the "A" and containing the top half of the "A", in triangle form.
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesDesign and development of pharmaceutical formulations; Research and development of oral drug delivery formulation used as facilitating agents for pharmaceutical tablets and capsules, vitamins, food supplements, and animal veterinary tablets and capsules; Development of pharmaceutical preparations in liquid time release form

Classification Information

International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status Code6 - Active
Class Status DateTuesday, April 25, 2017
Primary Code040
First Use Anywhere DateSunday, March 31, 2019
First Use In Commerce DateSunday, March 31, 2019
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, April 25, 2017
Primary Code042
First Use Anywhere DateSunday, March 31, 2019
First Use In Commerce DateSunday, March 31, 2019

Trademark Owner History

Party NameAdare Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressPhiladelphia, PA 19111
Party NameAdare Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressLawrenceville, NJ 08648
Party NameAdare Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressLawrenceville, NJ 08648

Trademark Events

Event DateEvent Description
Monday, July 24, 2017NON-FINAL ACTION E-MAILED
Saturday, April 22, 2017NEW APPLICATION ENTERED
Tuesday, April 25, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, April 26, 2017NOTICE OF DESIGN SEARCH CODE E-MAILED
Friday, July 14, 2017ASSIGNED TO EXAMINER
Monday, July 24, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, March 6, 2018PUBLISHED FOR OPPOSITION
Tuesday, March 6, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Monday, July 24, 2017NON-FINAL ACTION WRITTEN
Thursday, January 18, 2018EXAMINERS AMENDMENT -WRITTEN
Thursday, January 18, 2018EXAMINERS AMENDMENT E-MAILED
Thursday, January 18, 2018NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, January 18, 2018EXAMINER'S AMENDMENT ENTERED
Thursday, January 18, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Sunday, January 28, 2018ASSIGNED TO LIE
Wednesday, February 14, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 1, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, April 26, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 18, 2018SOU TEAS EXTENSION RECEIVED
Tuesday, September 18, 2018SOU EXTENSION 1 FILED
Tuesday, September 18, 2018SOU EXTENSION 1 GRANTED
Thursday, September 20, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 24, 2019SOU TEAS EXTENSION RECEIVED
Wednesday, April 24, 2019SOU EXTENSION 2 FILED
Wednesday, April 24, 2019SOU EXTENSION 2 GRANTED
Friday, November 1, 2019SOU TEAS EXTENSION RECEIVED
Friday, November 1, 2019SOU EXTENSION 3 FILED
Friday, November 1, 2019SOU EXTENSION 3 GRANTED
Tuesday, November 5, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, April 24, 2020SOU TEAS EXTENSION RECEIVED
Friday, April 24, 2020SOU EXTENSION 4 FILED
Friday, April 24, 2020SOU EXTENSION 4 GRANTED
Monday, November 2, 2020SOU EXTENSION 5 FILED
Tuesday, April 28, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 2, 2020SOU TEAS EXTENSION RECEIVED
Monday, November 9, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, November 9, 2020SOU EXTENSION 5 GRANTED
Wednesday, April 28, 2021TEAS STATEMENT OF USE RECEIVED
Monday, August 9, 2021SU - NON-FINAL ACTION - WRITTEN
Monday, August 9, 2021NON-FINAL ACTION E-MAILED
Monday, August 9, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, February 8, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, November 10, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 28, 2021USE AMENDMENT FILED
Monday, May 3, 2021STATEMENT OF USE PROCESSING COMPLETE
Friday, June 25, 2021ASSIGNED TO EXAMINER
Sunday, March 6, 2022ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, February 10, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, February 10, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, March 8, 2022NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, April 12, 2022REGISTERED-PRINCIPAL REGISTER
Thursday, February 20, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, February 20, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, February 20, 2025TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, February 20, 2025APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, February 20, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Related Keywords

capsules tablets pharmaceutical development food supplements veterinary animal agents vitamins